Have you heard the news? The DEA is considering moving cannabis to a Schedule III substance. This change in federal law would fundamentally shift the cannabis industry,...

Success in the California market often starts with a single shop. You learn the ropes, find your flow, and build a local brand. But as you scale...

Maximize the 280E cannabis tax dividend by restructuring debt and funding FDA compliance to ensure long-term success in 2026.

Prepare for the shift to Schedule III drugs as cannabis moves to FDA oversight. Learn about cGMP compliance, insurance risks, and avoiding federal enforcement actions.